Cage-type THGP octamer dissolves rapidly in water while maintaining neutral pH, eliminating the need for separate neutralization steps during administration.
IL-10 plasma concentration stratifies systemic lupus erythematosus patients to reduce corticosteroid requirements and improve therapeutic reliability.
Antibodies targeting specific TLR3 residues reduce cytokine production by over 50%, addressing insufficient inhibitory potency in existing antagonists.
Filipendula ulmaria extracts reduce hyperalgesia by inhibiting COX enzymes, avoiding neurological side effects of psychoactive medications.
Polyacrylamide hydrogel forms a stable sub-synovial layer within joints.
Bifidobacterium breve strain DSM 32583 enhances interleukin-10 expression in subjects.
Junctional protein modulators increase skin permeability to deliver high molecular weight agents without harsh solvents.
A topical composition using Phellodendron bark extract to cool skin and reduce heat.
Multi-strain Lactobacillus preparation overcomes transient therapeutic effects by establishing sustained vaginal niche colonization.
High-affinity humanized antibodies resolve low specificity of conventional inhibitors by blocking GM-CSF signaling pathways.
Phosphorylated dendrimers activate monocytes to reduce inflammation while avoiding tissue toxicity and high costs of conventional therapies.
Targeting the S100A9-TLR2 interaction reduces inflammatory responses without toxic side effects from traditional arthritis drugs.
A synthetic polypeptide composition mobilizes stem cells to arthritic sites and inhibits chondrocyte apoptosis.
Quinuclidinone derivatives use ester prodrugs and deuterium enrichment to resolve the contradiction between intravenous efficacy and oral accessibility.
Chrexanthomycins block TRPV1 channels, reducing capsaicin-induced pain without opioid side effects.
Alkaline water treatment of grape seed extracts yields urolithin-enriched dry powder.
Antibodies targeting the CSF-1R delD4 fragment inhibit ligand-independent proliferation and osteoclast differentiation.
Procyanidin B1 and B2 mediate active treatment of eosinophilic esophagitis, reducing inflammatory cell infiltration beyond dietary allergen avoidance.
Stromal vascular fraction cells enhance transplanted tissue vascularization, resolving the trade-off between rapid implantation and sufficient blood supply.
Combining a selective PDE4 inhibitor with cyclosporine A reduces inflammation and adverse reactions by synergistically blocking TNF-alpha release.